Interquim is an API manufacturer based in Mexico. It holds 20 active US drug master files across a filed portfolio of 22 molecules. Its GMP standing is certified by COFEPRIS (MX) and US FDA. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Spain, Spain | 3002807304 |
| Mexico, Mexico | 3005170172 |
| Cuautitlán Izcalli, Mexico | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Imiquimod | SFDA (Saudi Arabia), US FDA | 3 |
| Paliperidone | SFDA (Saudi Arabia), US FDA | 3 |
| Aripiprazole | US FDA | 2 |
| Celecoxib | SFDA (Saudi Arabia), US FDA | 2 |
| Ozenoxacin | SFDA (Saudi Arabia), US FDA | 2 |
| Rivastigmine | SFDA (Saudi Arabia), US FDA | 2 |
| Aripiprazole Lauroxil | US FDA | 1 |
| Ciclopirox | US FDA | 1 |
| Diacerein | SFDA (Saudi Arabia) | 1 |
| Diosmin | SFDA (Saudi Arabia) | 1 |
| Edaravone | US FDA | 1 |
| Ferric Carboxymaltose | US FDA | 1 |
| Lifitegrast | US FDA | 1 |
| Rasagiline | SFDA (Saudi Arabia) | 1 |
| Risperidone | US FDA | 1 |
| Rivaroxaban | US FDA | 1 |
| Roflumilast | US FDA | 1 |
| Rotigotine | US FDA | 1 |
| Sertaconazole | US FDA | 1 |
| Solifenacin Succinate | US FDA | 1 |
| Telmisartan | SFDA (Saudi Arabia) | 1 |
| Tolterodine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| COFEPRIS (MX) | None | 2 |
| US FDA | None | 1 |
Choose your molecules and target markets. Interquim comes back tiered against every other supplier able to file there.
Start for free